Covadonga Pañeda
Chief Operating Officer at ALTAMIRA THERAPEUTICS LTD.
Covadonga Pañeda active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Chief Operating Officer | 2022-12-31 | - |
| Corporate Officer/Principal | - | 2022-12-31 |
Career history of Covadonga Pañeda
Former positions of Covadonga Pañeda
| Companies | Position | Start | End |
|---|---|---|---|
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Corporate Officer/Principal | 2020-09-30 | 2022-03-31 |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Chief Tech/Sci/R&D Officer | 2011-02-28 | 2018-05-31 |
Training of Covadonga Pañeda
| Universidad Autónoma de Madrid | Doctorate Degree |
Statistics
International
| Spain | 3 |
| Bermuda | 2 |
| France | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
- Stock Market
- Insiders
- Covadonga Pañeda
- Experience